Association of Antiviral Therapy With Risk of Parkinson Disease in Patients With Chronic Hepatitis C Virus Infection

Messina, 2015, Global distribution and prevalence of hepatitis C virus genotypes., Hepatology, 61, 77, 10.1002/hep.27259

Negro, 2015, Extrahepatic morbidity and mortality of chronic hepatitis C., Gastroenterology, 149, 1345, 10.1053/j.gastro.2015.08.035

Gill, 2016, Hepatitis C virus as a systemic disease: reaching beyond the liver., Hepatol Int, 10, 415, 10.1007/s12072-015-9684-3

Olubamwo, 2016, Hepatitis C and risk of coronary atherosclerosis: a systematic review., Public Health, 138, 12, 10.1016/j.puhe.2016.04.005

Lin, 2014, The impact of hepatitis C infection on ischemic heart disease via ischemic electrocardiogram., Am J Med Sci, 347, 478, 10.1097/MAJ.0b013e3182a5587d

Pakpoor, 2017, Viral hepatitis and Parkinson disease: a national record-linkage study., Neurology, 88, 1630, 10.1212/WNL.0000000000003848

Wu, 2015, Hepatitis C virus infection: a risk factor for Parkinson’s disease., J Viral Hepat, 22, 784, 10.1111/jvh.12392

Tsai, 2016, Hepatitis C virus infection as a risk factor for Parkinson disease: a nationwide cohort study., Neurology, 86, 840, 10.1212/WNL.0000000000002307

Kim, 2016, Association between hepatitis C virus infection and Parkinson’s disease., Mov Disord, 31, 1584, 10.1002/mds.v31.10

Golabi, 2017, The prevalence of Parkinson disease among patients with hepatitis C infection., Ann Hepatol, 16, 342, 10.5604/01.3001.0009.8588

Nahon, 2017, Eradication of hepatitis C virus infection in patients with cirrhosis reduces risk of liver and non-liver complications., Gastroenterology, 152, 142, 10.1053/j.gastro.2016.09.009

Hsu, 2015, Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection., Gut, 64, 495, 10.1136/gutjnl-2014-308163

Lin, 2018, Antiviral therapy reduces risk of haemorrhagic stroke in patients with HCV infection: a nationwide cohort study., Antivir Ther, 23, 43, 10.3851/IMP3172

Wangensteen, 2016, Parkinsonism in patients with chronic hepatitis C treated with interferons: case reports and review of the literature., Clin Neuropharmacol, 39, 1, 10.1097/WNF.0000000000000120

Wangensteen, 2016, Hepatitis C virus infection: a risk factor for Parkinson’s disease., J Viral Hepat, 23, 535, 10.1111/jvh.2016.23.issue-7

Boyd, 2016, Hepatitis C virus infection as a risk factor for Parkinson disease: a nationwide cohort study., Neurology, 87, 342, 10.1212/01.wnl.0000489939.73359.c3

Abushouk, 2017, Evidence for association between hepatitis C virus and Parkinson’s disease., Neurol Sci, 38, 1913, 10.1007/s10072-017-3077-4

Wijarnpreecha, 2018, Hepatitis C virus infection and risk of Parkinson’s disease: a systematic review and meta-analysis., Eur J Gastroenterol Hepatol, 30, 9, 10.1097/MEG.0000000000000991

Yu, 2009, Treatment of chronic hepatitis C in Asia: when East meets West., J Gastroenterol Hepatol, 24, 336, 10.1111/jgh.2009.24.issue-3

Omata, 2012, APASL consensus statements and management algorithms for hepatitis C virus infection., Hepatol Int, 6, 409, 10.1007/s12072-012-9342-y

Perico, 2009, Hepatitis C infection and chronic renal diseases., Clin J Am Soc Nephrol, 4, 207, 10.2215/CJN.03710708

Younossi, 2013, Associations of chronic hepatitis C with metabolic and cardiac outcomes., Aliment Pharmacol Ther, 37, 647, 10.1111/apt.12234

Ascherio, 2016, The epidemiology of Parkinson’s disease: risk factors and prevention., Lancet Neurol, 15, 1257, 10.1016/S1474-4422(16)30230-7

De Pablo-Fernandez, 2018, Association between diabetes and subsequent Parkinson disease: a record-linkage cohort study., Neurology, 91, e139, 10.1212/WNL.0000000000005771

Lin, 2015, Association between Parkinson disease and risk of cancer in Taiwan., JAMA Oncol, 1, 633, 10.1001/jamaoncol.2015.1752

Lin, 2016, Statin therapy prevents the onset of Parkinson disease in patients with diabetes., Ann Neurol, 80, 532, 10.1002/ana.24751

Lin, 2015, Risk of Parkinson’s disease following anxiety disorders: a nationwide population-based cohort study., Eur J Neurol, 22, 1280, 10.1111/ene.2015.22.issue-9

Postuma, 2012, Identifying prodromal Parkinson’s disease: pre-motor disorders in Parkinson’s disease., Mov Disord, 27, 617, 10.1002/mds.24996

Lee, 2013, Discontinuation of statin therapy associates with Parkinson disease: a population-based study., Neurology, 81, 410, 10.1212/WNL.0b013e31829d873c

Kim, 2016, Use and interpretation of propensity scores in aging research: a guide for clinical researchers., J Am Geriatr Soc, 64, 2065, 10.1111/jgs.14253

Austin, 2011, An introduction to propensity score methods for reducing the effects of confounding in observational studies., Multivariate Behav Res, 46, 399, 10.1080/00273171.2011.568786

Austin, 2010, Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score., Am J Epidemiol, 172, 1092, 10.1093/aje/kwq224

De Virgilio, 2016, Parkinson’s disease: autoimmunity and neuroinflammation., Autoimmun Rev, 15, 1005, 10.1016/j.autrev.2016.07.022

Qin, 2016, Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: a systematic review and meta-analysis., JAMA Neurol, 73, 1316, 10.1001/jamaneurol.2016.2742

Zampino, 2013, Chronic HCV infection and inflammation: clinical impact on hepatic and extra-hepatic manifestations., World J Hepatol, 5, 528, 10.4254/wjh.v5.i10.528

Bokemeyer, 2011, Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy., Gut, 60, 370, 10.1136/gut.2010.217976

Forton, 2008, Cerebral immune activation in chronic hepatitis C infection: a magnetic resonance spectroscopy study., J Hepatol, 49, 316, 10.1016/j.jhep.2008.03.022

Weissenborn, 2006, Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment., Gut, 55, 1624, 10.1136/gut.2005.080267

Marín-Serrano, 2006, Modulation of the anti-inflammatory interleukin 10 and of proapoptotic IL-18 in patients with chronic hepatitis C treated with interferon alpha and ribavirin., J Viral Hepat, 13, 230, 10.1111/jvh.2006.13.issue-4

Fletcher, 2012, Hepatitis C virus infects the endothelial cells of the blood-brain barrier., Gastroenterology, 142, 634, 10.1053/j.gastro.2011.11.028

Fletcher, 2012, Hepatitis C virus and the brain., J Viral Hepat, 19, 301, 10.1111/jvh.2012.19.issue-5

Fishman, 2008, Molecular and bioinformatic evidence of hepatitis C virus evolution in brain., J Infect Dis, 197, 597, 10.1086/587088

Radkowski, 2002, Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication., J Virol, 76, 600, 10.1128/JVI.76.2.600-608.2002

Vargas, 2002, Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation., Liver Transpl, 8, 1014, 10.1053/jlts.2002.36393

Pan, 1997, Permeability of the blood-brain and blood-spinal cord barriers to interferons., J Neuroimmunol, 76, 105, 10.1016/S0165-5728(97)00034-9

Goldman, 2014, Premotor and nonmotor features of Parkinson’s disease., Curr Opin Neurol, 27, 434, 10.1097/WCO.0000000000000112

Mollenhauer, 2012, Biochemical premotor biomarkers for Parkinson’s disease., Mov Disord, 27, 644, 10.1002/mds.24956

Reichmann, 2017, Premotor diagnosis of Parkinson’s disease., Neurosci Bull, 33, 526, 10.1007/s12264-017-0159-5

Colombo, 2011, Brain distribution of ribavirin after intranasal administration., Antiviral Res, 92, 408, 10.1016/j.antiviral.2011.09.012

Kajihara, 2010, Parkinsonism in patients with chronic hepatitis C treated with interferon-alpha2b: a report of two cases., Eur J Gastroenterol Hepatol, 22, 628, 10.1097/MEG.0b013e32833383e3

Ritz, 2010, L-type calcium channel blockers and Parkinson disease in Denmark., Ann Neurol, 67, 600, 10.1002/ana.21937

Pasternak, 2012, Use of calcium channel blockers and Parkinson’s disease., Am J Epidemiol, 175, 627, 10.1093/aje/kwr362

Lee, 2014, Antihypertensive agents and risk of Parkinson’s disease: a nationwide cohort study., PLoS One, 9, e98961, 10.1371/journal.pone.0098961

National Health Insurance Administration, Ministry of Health and Welfare. 2014-2015 National Health Insurance annual report. http://www.nhi.gov.tw/Resource/webdata/28140_1_National%20Health%20Insurance%20in%20Taiwan%202014-2015%20(bilingual).pdf. Accessed April 29, 2015.